Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tasche

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Experimental & Molecular Medicine|July 1, 2018
Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalusClaudia Dafinger, Markus M Rinschen, Lori Borgal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.
Head & Neck|June 26, 2020
Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelinesGregory S Weinstein, Roger Cohen, Alexander Lin, et al.
Oral Oncology|September 21, 2023
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary centerChadi N Abdel-Halim, Thomas J O'Byrne, Jeffrey P Graves, et al.
Audiology & Neuro-Otology|January 15, 2005
Normative findings of electrically evoked compound action potential measurements using the neural response telemetry of the Nucleus CI24M cochlear implant systemD Cafarelli Dees, N Dillier, W K Lai, et al.
Oral Oncology|May 18, 2025
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinomaBrennan Olson, Aaron Bogan, Chadi N Abdel-Halim, et al.
JAMA Network Open|May 18, 2026
De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal CancerCecelia M Hidalgo, Aaron W Bogan, Katelyn S Rourk, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Experimental & Molecular Medicine|July 1, 2018
Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalusClaudia Dafinger, Markus M Rinschen, Lori Borgal, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.
Head & Neck|June 26, 2020
Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelinesGregory S Weinstein, Roger Cohen, Alexander Lin, et al.
Oral Oncology|September 21, 2023
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary centerChadi N Abdel-Halim, Thomas J O'Byrne, Jeffrey P Graves, et al.
Audiology & Neuro-Otology|January 15, 2005
Normative findings of electrically evoked compound action potential measurements using the neural response telemetry of the Nucleus CI24M cochlear implant systemD Cafarelli Dees, N Dillier, W K Lai, et al.
Oral Oncology|May 18, 2025
Identification of clinical and pathologic features associated with extranodal extension in patients with HPV-mediated oropharyngeal squamous cell carcinomaBrennan Olson, Aaron Bogan, Chadi N Abdel-Halim, et al.
JAMA Network Open|May 18, 2026
De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal CancerCecelia M Hidalgo, Aaron W Bogan, Katelyn S Rourk, et al.
Pageof 11